Quality of Life With TESTIM® (LIFE)

Ferring

Status: Completed

Conditions: Hypogonadism

Study type: Observational

Funder types: Industry

Identifiers

NCT01148433

FE999303 CS01

Details and patient eligibility

About

The present non-interventional study is to document the testosterone levels in patients with clinical symptoms such as loss of sexual desire indicating hypogonadism (testosterone deficiency syndrome). During testosterone replacement therapy with TESTIM®, the changes in the quality of life - especially with respect to motivation, activity and fatigue - of hypogonadal patients will be documented and correlated with the testosterone levels during the course of therapy.

Enrollment: 157 patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• therapeutic need according to SPC
• written informed consent

Exclusion criteria

• contraindications according to SPC

Trial design

157 participants in 1 patient group

TESTIM® - drug given by prescription

Description:

Male patients with Hypogonadism